Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination항인지질항체 양성 환자의 항PF4 항체 생산은 코로나19 예방접종에 영향을 받지 않는다Article Published on 2022-02-012022-09-12 Journal: RMD Open [Category] MERS, 진단, [키워드] absence activate administration Affect aggregation antibodies antibody Antiphospholipid association Asymptomatic carriers cationic chemokine clinical manifestation clinical manifestations Control control groups COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines described ELISA heparin heparin-induced thrombocytopenia Immunoglobulin in vitro infections mRNA-based not affect not affected Patient patients patients with COVID-19 Platelet platelet activation positive Production serum subject syndrome systemic lupus erythematosus tested thrombosis titre Treatment vaccination [DOI] 10.1136/rmdopen-2021-001902 PMC 바로가기 [Article Type] Article
Epidemiological characteristics and outcomes of COVID-19 in asymptomatic versus symptomatic patients무증상 환자와 유증상 환자에서 코로나19의 역학적 특성과 결과Article Published on 2022-01-312022-09-11 Journal: Journal of preventive medicine and hygiene [Category] SARS, 치료기술, [키워드] acute respiratory disease Asymptomatic Asymptomatic carriers Asymptomatic case Asymptomatic cases asymptomatic individual Asymptomatic individuals asymptomatic infection asymptomatic infections asymptomatic patient asymptomatic patients Characteristics Chi-square chi-square test clinical manifestation clinical manifestations clinical symptom Clinical symptoms Contact contact with COVID-19 COVID-19 in patient epidemiological evaluate investigated Iran males mortality rate Older outcome Patient patients Patients with clinical symptoms. patients with COVID-19 Pneumonia qualitative variables retrospective cohort study study groups symptomatic cases symptomatic patient Symptomatic patients the disease two group two groups variable Viral load was used [DOI] 10.15167/2421-4248/jpmh2021.62.4.2254 PMC 바로가기 [Article Type] Article
The Positive Rate of Nucleic Acid Testing and the Epidemiological Characteristics of COVID-19 in ChongqingMedicine Published on 2022-01-142022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] acid acute respiratory syndrome Analysis Asymptomatic carrier Asymptomatic carriers Blood Characteristics Chongqing clinics close contact close contacts collected conducted coronavirus COVID-19 death defined detection rate diagnosed Diagnosis diagnostic died effective Epidemic epidemiological epidemiological data Fever Frequency groups human-to-human transmission identify IMPROVE increased risk indicated Infection latency median nucleic acid nucleic acid test objective observation one patient Patient populations positive positive rate positive test result potential transmission Rate receiving reported Result Retrospective study SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid SARS-CoV-2 test statistical analysis Suspected cases tested Testing the median the SARS-CoV-2 Threats were used [DOI] 10.3389/fmed.2021.802708 PMC 바로가기 [Article Type] Medicine
The Genomic Physics of COVID-19 Pathogenesis and SpreadCOVID-19 발병 및 확산의 게놈 물리학Review Published on 2021-12-282022-09-11 Journal: Cells [Category] SARS, 유전자 메커니즘, [키워드] Asymptomatic carrier Asymptomatic carriers characterized close contact Community coronavirus coronavirus disease COVID-19 disease Effect effective facilitate Genetic genetic loci genetic mechanism Genome help horizontal epistasis hypergraph Mitigation molecular molecular mechanism molecular mechanisms Pathogenesis person-to-person transmission Physics Quantitative recipient Screen Spread statistical Statistical physics susceptible the disease Transmissibility Transmission transmitter Triage Viral viral genomes virus [DOI] 10.3390/cells11010080 PMC 바로가기 [Article Type] Review
Summary report of seven cases of COVID-19 infection in renal transplant recipients신장이식 수혜자 코로나19 감염 7건 요약 보고Article Published on 2021-12-012022-09-11 Journal: Transplant immunology [Category] MERS, SARS, 진단, 치료제, [키워드] Acute kidney injury adjusted adopted Allograft Antibiotics antiviral drugs Asymptomatic Asymptomatic carrier Asymptomatic carriers clinical manifestations coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection Critical critical patients died different clinical manifestations discharged ENhance FIVE Health High-dose Immunity Immunoglobulin Immunosuppressant immunosuppressants immunosuppressive agent Immunosuppressive agents infected with COVID-19 Infection Inflammation inhibit Intravenous immunoglobulin Isolation IVIG low-dose management Methylprednisolone Mild mild patients moderate moderate or severe patients one patient outcome Patient patients with COVID-19 Prognosis recipient reduced rejection renal Renal transplant reported reversal SARS-CoV-2 SARS-CoV2 Seven severe patients therapy treated Treatment was used were used [DOI] 10.1016/j.trim.2021.101445 PMC 바로가기 [Article Type] Article
Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms백신 접종 전 단계에서 멕시코에서 SARS-CoV-2의 계통유전체학 및 인구유전체학은 관심 변이 B.1.1.28.4 및 B.1.1.222 또는 B.1.1.519 및 증상과 관련된 뉴클레오캡시드 돌연변이 S194L을 나타냅니다Research Articles Published on 2021-11-302022-09-10 Journal: Microbial Genomics [Category] MERS, SARS, 변종, 치료기술, 치료법, [키워드] adaptive addition allelic Analysis Asymptomatic Asymptomatic carriers baseline carrier clades Clinical data complementary COVID-19 pandemic disease dual E484K Effect Evolution Evolution of SARS-CoV-2 fixed Follow-up Frequency Genetic Genome genomes help highlight Host lack Mexico mitigate Mutation N-terminal domain nucleocapsid nucleocapsid protein Nucleocapsid proteins nucleotide pandemic phenotypic Phylogenomics population genomics pre-vaccination Prevalence Protein quantitative PCR raising receptor-binding motif Region reveal SARS-CoV-2 SARS-CoV-2 virus Single nucleotide variant single nucleotide variants spike and nucleocapsid proteins spike glycoprotein Spike protein Symptom symptomatic and asymptomatic Symptomatic patients T478K the SARS-CoV-2 virus understanding vaccination variant variants variants of interest virus [DOI] 10.1099/mgen.0.000684 PMC 바로가기 [Article Type] Research Articles
Asymptomatic detection of SARS‐CoV‐2 among cancer patients receiving infusional anti‐cancer therapy주입형 항암치료를 받는 암환자에서 무증상 SARS-CoV-2 검출Research Article Published on 2021-10-282022-09-10 Journal: Cancer Medicine [Category] MERS, SARS, 치료기술, [키워드] active cancer Analysis Asymptomatic Asymptomatic carrier Asymptomatic carriers Cancer cancer patient Cancer patients carrier Clinical outcome Cohort cohort analysis Complication complications COVID‐19 infection COVID‐19 described detection develop died examined help Hospitalization immunomodulating Infusion Therapy majority median Mortality myelosuppressive outcome outcomes Patient patients required hospitalization Patients with cancer PCR testing positive Primary outcome protocol receiving remained required Result SARS‐CoV‐2 SARS‐CoV‐2 infection SARS‐CoV‐2 PCR SARS‑CoV2 Screening secondary Secondary outcomes symptomatic Symptoms Therapies therapy undergo understanding [DOI] 10.1002/cam4.4373 PMC 바로가기 [Article Type] Research Article
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population ( CoV-Surv Study ): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling일반 인구에서 SARS-CoV-2 감시를 위한 4가지 다른 전략의 효과 및 비용 효율성( CoV-Surv 연구 ): 클러스터 샘플링을 사용하는 2단계 무작위 통제 다중군 시험을 위한 연구 프로토콜Study Protocol Published on 2021-09-262022-09-10 Journal: Trials [Category] SARS, 임상, 치료기술, 치료제, [키워드] Active surveillance analyzed approach Arm ARMS Asymptomatic Asymptomatic carrier Asymptomatic carriers clinical Cluster Course COVID-19, Cluster-randomised controlled trial, Protocol, Population-based surveillance, Cost-effectiveness, Implementation, Pandemic detection rate disease effective Effectiveness estimate General population group identify include infected individual infected individuals Laboratory Local multi-arm outbreak outcome pandemic Pandemics parameter participant population groups positive Precision predict Prevalence Primary outcomes Randomized related disease representing Saliva saliva samples Sample size SARS-CoV-2 surveillance SARS-CoV-2 testing screened Strategy Study protocol Surveillance Symptom System tested Trial Trial registration user experiences while [DOI] 10.1186/s13063-021-05619-5 PMC 바로가기 [Article Type] Study Protocol
A discussion on the minimum required number of tests in two common pooling test methods for SARS-CoV-2SARS-CoV-2에 대한 두 가지 일반적인 풀링 테스트 방법의 최소 요구 테스트 수에 대한 논의Comparative Study Published on 2021-08-032022-09-11 Journal: Epidemiology and Infection [Category] MERS, SARS, 진단, 치료기술, [키워드] Asymptomatic carrier Asymptomatic carriers carrier carriers COVID-19 effective Health infection rate optimization pandemic parameter pool pool testing pooling reduction in required Result SARS-CoV-2 virus [DOI] 10.1017/S0950268821001667 PMC 바로가기 [Article Type] Comparative Study
Mass Screening of Asymptomatic Persons for Severe Acute Respiratory Syndrome Coronavirus 2 Using Saliva타액을 이용한 중증급성호흡기증후군 코로나바이러스 2에 대한 무증상자 집단 스크리닝Comment Published on 2021-08-022022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 치료기술, [키워드] Accuracy acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Asymptomatic Asymptomatic carriers Chain Reaction Cohort Concordance conducted Containment coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 correlated COVID-19 credible interval detection disease global pandemic individual individuals LAMP mass Mass screening Nasopharyngeal swab NPs nucleic acid nucleic acid amplification nucleic acid amplification testing outbreak PCR Person polymerase chain polymerase chain reaction Polymerase chain reaction testing positive Prevalence Probability quarantine respiratory Saliva saliva samples saliva specimen saliva specimens saliva test SARS-CoV-2 Screening sensitivities sensitivity Sensitivity and specificity severe acute respiratory syndrome Coronavirus Specificities specificity specimen Transmission utility Viral load virus [DOI] 10.1093/cid/ciaa1388 PMC 바로가기 [Article Type] Comment